To investigate the mechanism by which treatment of normal human erythrocytes with the sulfhydryl reagent 2-aminoethylisothiouronium bromide (AET) induces susceptibility t o complement mediated lysis, the effects of AET on the structural and functional integrity of decay accelerating factor (DAF), membrane inhibitor of reactive lysis (MIRL), and complement receptor type 1 (CR1) were examined. Following treatment with AET, erythrocyte MlRL and CR1 were no longer recognized in situ by antibodies, and antibody binding to DAF was diminished by approximately 50%. These studies indicated that the structural integrity of the three complement regulatory proteins was either partially (DAF) or completely (MIRL and CRI) disrupted by AET. Subsequent experiments showed that functional inactivation paralleled the structural disruption. Treatment of normal erythrocytes with AET induced susceptibility t o cobra venom factor-initiated hemolysis, indicating that the functional activity of MlRL had ORMAL HUMAN erythrocytes are relatively resis-N tant to complement-mediated hemolysis because of the presence of four membrane constituents that regulate the functional activity of the complement system. Complement receptor type I (CRl), a glycoprotein with an M, of 160 to 250 Kd (depending on the allotype) restricts complement activity in two First, it has decay accelerating activity for the C3 convertase of both the classical and alternative pathway of complement (APC).lS6 Second, it acts as a cofactor for the enzymatic degradation of C3b by factor I.' Decay accelerating factor (DAF) is a 70-Kd glycoprotein that, like CR1, limits the formation and stability of the C3 convertases of both the classical pathway of complement and the APC.6 Unlike CR1, however, DAF has no cofactor activity. C8 binding protein (C8bp)' or homologous restriction factor (HRF)' is a 65-Kd protein that has been reported to inhibit the cytolytic activity of the membrane attack complex (MAC) of complement. Recently, we have isolated an 18-Kd protein called membrane inhibitor of reactive lysis (MIRL) that restricts complement-mediated hemolysis by blocking formation of the MAC."' Working been destroyed. The capacity of erythrocyte CR1 to serve as a cofactor for factor I-mediated cleavage of iC3b t o C3c and C3dg was lost following treatment with AET. C3 convertase activity increase markedly following treatment of erythrocytes with AET, but convertase activity on AET cells was approximately 50% less than that observed when DAF function on normal cells was completely inhibited by antibody. Susceptibility of AET cells t o acidified serum lysis was shown t o be due primarily t o inactivation of MIRL. Unexpectedly, in acidified serum the activity of the amplification C3 convertase of the APC was found t o be controlled by MlRL as well as by DAF. These studies show that AET induces susceptibility t o complement-mediated lysis by disrupting the structural and functional integrity of membrane constituents that regulate the activity of both the C3 convertases and the membrane attack complex of complement.
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independently, others have also identified the MIRL protein and characterized some of its structural and functional features.'*-** Unlike the majority of integral membrane proteins that are bound to the cell through a hydrophobic transmembrane domain, DAF,Z3,*4 HRF/C8bp,25 and MIRL" are anchored to the cell surface through a glycosyl phosphatidylinositol (GPI) moiety. This structural feature is common to a group of proteins that are deficient in paroxysmal nocturnal hemoglobinuria (PNH).Z6 Compelling evidence indicates that the enhanced susceptibility of PNH erythrocytes to complement-mediated hemolysis is due to deficiencies of DAF27-29 and MIRL.9%10 However, the contribution of the deficiency of HRF/C8bp to the enhanced susceptibility has been less clearly defined.3"."
CR1 differs from the other complement regulatory proteins in that it is anchored to the cell membrane in the more conventional way (through a hydrophobic transmembrane domain).32 Further, while quantitative studies have shown that PNH erythrocytes have lower than normal amounts of CRl,33-35 the partial deficiency appears to be an epiphenomenon that results from exposure of the erythrocytes to complement activation in vivo. The contribution of this acquired deficiency of CR1 to the aberrant interactions of PNH erythrocytes with complement remains speculative.
Based on susceptibility to antibody-initiated complementmediated lysis, PNH erythrocytes have been divided into the following three categories: PNH I cells are normal or nearly normal in susceptibility; PNH I1 cells are 3 to 5 times more susceptible; and PNH I11 erythrocytes are 15 to 25 times more susceptible than normal. Recent studies have shown that relatively subtle quantitative differences in expression of membrane complement regulatory proteins underlie the variability in complement sensitivity.'" Those investigations demonstrated that PNH Ill erythrocytes are markedly deficient in both DAF and MIRL. While both proteins, the deficiencies were less profound and PNH I cells were less severely affected than PNH I1 cells.
In 1965, Sirchia et a136 reported that normal human erythrocytes treated with the sulfhydryl reagent 2-aminoethylisothiouronium bromide (AET) manifested a sensitivity to complement similar to that observed for PNH erythrocytes. Subsequently, AET cells have been used in studies aimed at determining the nature of the aberrant interactions of complement with PNH cells.33s37,38 Phenotypically, AET cells resemble the most complement-sensitive PNH I11 cells in that they have a similar hemolytic profile in the complement lysis sensitivity assay,37 they are hemolyzed in acidified serum,36 and they are susceptible to hemolysis initiated by cobra venom factor (COF)?~ Further, like PNH I11 erythrocytes, AET cells bind relatively large amounts of C5b-9 during CoF-initiated However, unlike PNH I11 erythrocytes, AET cells bind only slightly more C3b than normal erythrocytes following activation of the classical pathway of c0mplement.3~
The mechanism whereby AET induces the transformation of normal erythrocytes into the PNH-like phenotype has been controversial. However, recent observations on the effects of reducing agents on MIRL appear to have provided new insights into the basis of the AET-induced transformation. We have observed that in Western blotting experiments, MIRL was not recognized by antibody when the sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed under reducing condit i o n~.~ Further, following treatment with AET, erythrocytes no longer bind anti-MIRL antibody." Together, those results suggest that AET destroys the structural and functional integrity of MIRL by disrupting intrachain disulfide bonds. To define more precisely the basis for the enhanced susceptibility of AET cells to complement-mediated hemolysis, the effects of AET on the structural and functional integrity of MIRL, DAF, and CR1 were investigated.
MATERIALS AND METHODS

Bufers.
The following buffers were used: veronal-buffered saline (VBS) containing 10 mmol/L sodium barbital (Sigma Chemical Co, St Louis, MO), pH 7.5 and 145 mmol/L NaC1; VBS containing 0.1% gelatin (GVB); GVB containing 1 mmol/L MgCl, (GVB'); GVB', pH 6.4 was prepared by titrating GVB' with 1 molL HCl; GVB containing 15 mmol/L EDTA (GVB-EDTA); GVB containing 0.15 mmol/L NiCI, (GVB-Ni); phosphatebuffered saline (PBS) containing 150 mmol/L sodium chloride and 10 mmoliL sodium phosphate, pH 7.4.
Preparation of AET erythrocytes. Erythrocytes from normal donors were obtained by phlebotomy and stored in Alsever's solution at 4°C. AET was purchased from Sigma Chemical Co. Normal erythrocytes were washed three times in PBS, and after each wash the top 10% of the cell pellet was aspirated to remove the bu@ coat. An aliquot of 1 mL of packed cells was added to 4 mLof an 8% (wthol) solution of AET that had been titrated to pH 8.0 with HCl.3' The mixture was incubated at 37°C with constant agitation. After exactly 9 minutes, the cells were washed three times with GVB.
Polyclonal antiserum against MIRL and DAF was prepared using previously described methods.' Monoclonal antibody (MoAb) against CR13' was a gift from Dr Eric Brown (Washington University School of Medicine,
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St Louis, MO). The IgG was isolated from ascites by using capryllic acid? Monoclonal anti-C3d was purchased from Quidel (San Diego, CA). The antibody recognizes an epitope that is located in the C3d region of C3 and that is expressed by C3b, iC3b, C3dg, and C3d. Afhity-purified antimouse IgG and monoclonal antirabbit IgG were purchased from Sigma Chemical Co. The monoclonal antirabbit IgG was in the form of ascites, and the IgG was isolated by using capryllic aci d!'
CoF, C3, factor B, factor D, and C3 nephritic factor were isolated using methods that have been previously de~cribed.~' Protein concentrations were determined either spectrophotometrically4' or by using the bichinchoninic acid (BCA) protein assay (Pierce Chemical Co, Rockford, IL) using bovine serum albumin (BSA) as the standard. Activated CoF complexes (CoFBb) were prepared according to reference 9.
Monoclonal anti-C3d, monoclonal antirabbit IgG, affinity-purified antimouse IgG, and human C3 were labeled with as NaI (Amersham Corp, Arlington Heights, IL) by using IODO-GEN (Pierce Chemical Co)!' SDS-PAGE and autoradiography. Analysis of proteins by SDS-PAGE was performed using linear gradient gels of 6% to 15%.' Molecular weights were estimated by reference to I4C-Iabeled standards purchased from Amersham Corp.' Autoradiographs were prepared by exposing dried gels to X-Omat AR film (Eastman Kodak Co, Rochester, NY) at -700C.9
Quantitation of MIRL, DAF, and CRI on normal and AET erythrocytes. Quantitation of MIRL, DAF, and CR1 by using an indirect radioimmunobinding assay was performed using a minor modification of the method of Holguin et al"' in that radiolabeled monoclonal antirabbit IgG (for MIRL and DAF quantitation) or affinity-purified antimouse IgG (for CR1 quantitation) were substituted for radiolabeled affinity-purified polyclonal antirabbit IgG. In each case, equilibrium binding studies were performed to determine the amount of the primary and secondary antibodies that were required to produce saturation binding.
Susceptibility of AET erythrocytes to lysis by CoFBb complexes. AET erythrocytes were incubated with CoFBb and incremental concentrations of normal serum (the complement source) that had been chelated with EDTA. The methods for these experiments are described in detail in reference 9.
Determination of CRI cofactor activity on normal and AET cells. Normal and AET erythrocytes bearing radiolabeled C3b were prepared using methods that have been described in detail!' Briefly, normal and AET cells bearing the nephritic factorstabilized APC C3 convertase were incubated with radiolabeled C3. After washing, each set of cells was divided into equal aliquots, and one aliquot was incubated at 37°C with heat-inactivated serum as a source of factor H and factor I according to the method of Ross et aLM The other aliquot was incubated with GVB. After 30 minutes, the cells were washed with GVB-EDTA. Next, hemoglobin-free ghosts were prepared, and membrane proteins were solubilized in SDS.43 Ester-bound activation and degradation products of C3 were dissociated by incubating the membrane proteins in 1 molL NH,OH at alkaline PH.~' After dialysis, C3 fragments were analyzed by SDS-PAGE and a~toradiography.~'
Determination of the activity of the amplification C3 convertase of the APC on erythrocytes. The procedure has been described in detail elsewhere." Briefly, erythrocytes were washed three times with GVB and resuspended to 1 x lD9/mL. To serve subsequently as a control for nonspecific binding of radiolabeled anti-C3d, an aliquot of 100 KL was diluted to 500 )IL in GVB and stored on ice. To form the nidus for formation of the amplification C3 convertase, cells were incubated with C3 and activated CoF complexes. After washing, an aliquot of these cells called EC3b, was resuspended to 2 x 10*/mL and kept on ice for subsequent determination of the amount of C3b bound. The remainder of the EC3bI was washed in
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For personal use only. on October 30, 2017. by guest www.bloodjournal.org From 2766 EZZELL ET AL GVB-Ni, and the nickel-stabilized C3 convertase (C3bBb) was generated by incubating the cells at 37°C with factor B and factor D. After 3 minutes, the cells were washed once in GVB-Ni, 100 pL of C3 (2.5 mg/mL) were added, and the incubation was continued. After 20 minutes, the cells (called EC3b,) were washed three times in GVB and resuspended to 2 x 1O8/mL. The amount of C3b on EC3b, and ECSb,, was determined by using radiolabeled anti-C3d. 45 In triplicate, 50-pL aliquots of the samples were incubated with 50 pLof monoclonal radiolabeled anti-C3d (20 pg/mL) at 37°C. After 30 minutes, 75 p L of the sample was pipetted onto 300 pL of a mixture of phthalate esters contained in 400-pL microfuge tubes. Following centrifugation (Beckman Microfuge 12, Beckman Instruments, Inc, Palo Alto, CA) for 3 minutes at 8,000g, the tips containing the cells were cut off, and the radioactivity of the pellet was quantified in a gamma counter. The radioactivity of the control samples was subtracted to determine specific binding. Binding of lB5I-anti-C3d was calculated based on specific activity and an M, of 160 Kd.
Effects of blocking DAF, MIRL, and CRI on the activity of the amplification C3 convertase of the APC. Anti-DAF, anti-MIRL, and nonimmune rabbit serum were chelated by adding EDTA to a final concentration of 10 mmol/L and incubating the mixture for 5 minutes at 37°C. Normal and AET erythrocytes were incubated with saturating amounts of anti-DAF, anti-MIRL, or anti-CR1 either alone or in combination. For controls, nonimmune rabbit serum or GVB was substituted for the antisera or for the anti-CR1 IgG, respectively. Next, the cells were washed and C3 convertase activity was determined by using the two-step procedure described above.
Acidified serum was prepared by mixing 125 pL 0.2 mol/L HCI with 875 pLof normal human serum (NHS). The final pH of the serum was 6.4. In all of the experiments reported here, acidified serum contained 2.5 mmol/L MgCI, and 8 mmol/L EGTA. This reagent was prepared by mixing 1 volume of a stock solution of 25 mmol/L MgCI, and 80 mmol/L EGTA (Sigma Chemical Co), pH 6.4 with 9 volumes of acidified serum and incubating the mixture for 5 minutes at 37°C.
Acidified NHS containing 10 mmol/L EDTA (acidified NHS-EDTA) was prepared by mixing 1 volume of 100 mmol/L EDTA, pH 6.4 with 9 volumes of NHS, pH 6.4 and incubating the mixture for 5 minutes at 37°C. This reagent was used as a negative control in the acidified serum lysis experiments.
To ensure that Mg/EGTA serum did not support activation of the classical pathway of complement, sheep erythrocytes bearing antibody (EA) were prepared. Next, the EA were incubated at 37°C with incremental concentrations of either NHS, NHS-Mg/ EGTA (pH 7.4), or NHS-EDTA. After 30 minutes, the mixtures were centrifuged and hemolysis was quantitated by measuring free hemoglobin. Less than 1 pL of NHS supported lysis of 60% of the EA, whereas no lysis was observed using 50 pL of either NHS-Mg/ EGTA or NHS-EDTA. Erythrocytes were washed three times in GVB, once in GVB', pH 6.4 and resuspended to 5 x 10'/mL. Dilutions of acidified serum were prepared using GVB', pH 6.4 as the diluent. Aliquots of 50 pL of cells were incubated at 37°C with 100 pL of the appropriate dilution of acidified serum. At the same time, cells were incubated with reagents that served to control for spontaneous lysis in the presence of buffer or acidified NHS-EDTA. Lysis of 100% of the cells was achieved by using 0.04% NH,OH. After 30 minutes, 850 pL of GVB-EDTA were added, the samples were transferred to 1.5-mL microfuge tubes and centrifuged for 5 minutes at 11,5008. An aliquot of 100 pL of supernate was recovered and free
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hemoglobin was determined by measuring the A410. The values were used to calculate hemolysis.' Effects of blocking DAF, MI", and CRI on the susceptibility of eythrocytes to acidified serum lysis. Normal and AET erythrocytes were washed three times in GVB and resuspended to 5 x 108/mL. Anti-DAF, anti-MIRL, and anti-CR1 and control reagents were prepared as described above. Erythrocytes were incubated at 37°C with optimal concentrations of the antibodies and the control reagents either alone or in combination. After 30 minutes, the cells were washed once with 4 mL of GVB', pH 6.4 and resuspended to 5 X 10*/mL. Aliquots of 50 pL of cells were incubated with 100 pL of the appropriate dilution of acidified serum, and hemolysis was quantified subsequently as described above.
Quantitation of C3 deposition on erythrocyte membranes following incubation in acid$ed serum. Following removal of an aliquot of the supernate for determination of free hemoglobin, the remainder of the supernate was aspirated and the cells were resuspended to 100 pL in GVB-EDTA. In duplicate, 40 pL of cells were incubated at 37°C with 50 pL of radiolabeled anti-C3d (20 pLgimL). Pilot experiments had shown that this concentration of antibody was saturating. After 30 minutes, aliquots of 75 pL of each reaction mixture were pipetted into a 400-pL polyethylene microfuge tube containing 300 pL of 20% sucrose.41 After centrifugation in the microfuge for 15 minutes at 11,50Og, the tips containing the cells were cut off, and the radioactivity of the pellet was quantified in a gamma counter. The radioactivity of the control samples was subtracted to determine specific binding. Binding of '=I-anti-C3d was calculated based on specific activity and an M, of 160 Kd.
RESULTS
Effects of AET on recognition of erythrocyte DAF, MZRL, and CRl' by antibody. Following treatment of normal erythrocytes with AET, binding of anti-MIRL and anti-CR1 was abolished, suggesting that AET had disrupted the structural integrity of the two proteins (Table 1) . In contrast, binding of anti-DAF to AET cells was only partially diminished (Table 1) . These results are consistent with the concept that following treatment with AET a portion of erythrocyte DAF remains structurally intact.
Effects of A E T on the functional intepi'ty of DAF, MZRL,
and CRl. The experiments described above suggested that the structural integrity of the three complement regulatory proteins was either partially or completely destroyed by AET. The following experiments were performed to test the effects of AET on the functional integrity of MIRL, CR1, and DAF.
Normal human erythrocytes are resistant to CoFBbinduced hemolysis because MIRL blocks assembly of the For
attack complex on the cell surfacc.P Howcvcr, trcatmcnt with AET causcd normal cclls to bccomc markedly scnsitivc to CoFBh-induccd hcmolysis (Fig 1) . Thew rcsults. along with thosc shown in Tahlc I, indicatc that AET disrupts thc functional as wcll as thc structural intcgrity of MIRL.
Erythrocytc CRl has two known functions. First, it has dccay-accclcrating activity for thc amplification convcrtasc of the APC.' Sccond, it scrvcs as a cofactor for factor I mcdiatcd clcavagc of C3b and iC3b.' To tcst thc cffccts of AET on CRl cofactor activity, normal and AET crythrocytcs bcaring radiolahclcd C3b wcrc incuhatcd with hcatinactivatcd serum as a sourcc of factor H and factor I. "
Mcmhranc-associatcd C3 was suhscqucntly analyzcd by SDS-PAGE and autoradiography. As cvidcnccd by thc virtual ahscncc of thc a chain of C3b and iC3b (am), csscntially all of thc C3b bound to normal crythrocytcs incuhatcd in hcat-inactivated scrum was dcgradcd past the stagc of iC3b (Fig 2. lanc 2) .
Factor H can scrvc as a cofactor for factor I-mediated clcavagc of C3b to iC3b. but CRI cofactor activity is rcquircd for factor I-mcdiatcd clcavagc of iC3b to C3c and C3dg." Thus, thc prcscncc of a promincnt a68 band in lanc 3 of Fig 2 indicatcs that AET has dcstroycd thc cofactor activity of CR 1.
As cvidcnccd by thc presence of the a chain of C3b, when normal (Fig 2. lane 4) and AET (Fig 2. 
30-
Fig2 Elf.cbofAETonCR1cof.ctorutiviiy.R.did.ktadC3b was deposited on nonnal and AETefythmqtes using isolated campownts of the APC. A portion of the cells were incubated with heat-inactivated serum as a source of factor H and factor I. As controls, an equal portion of cells wefe incubated with buffer. After washing. hemoglobin-free ghosts were prepared. Membrane proteins were solubiiized using SDS and treated with NH,OH at alkaline pH t o disrupt ester-bound C3b. After dialysis, the radiolabeled C3 was analyzed by SDS-PAGE (reducing conditions) and autoradiography. Lane 1, radiolabeled C3; lane 2, normal erythrocytes bearing C3b that had bwn incubated in heat-inactivated serum; lane 3. AET erythroq t e s bearing C3b that had been incubated in heat-inactivated serum; lane 4, normal erythrocytes bearing C3b that had been incubated In buffer; lane 5, AET erythrocytes bearing C3b that had been incubated in buffer. Left, the positions of the molecular weight standard am indicated. Right, the positionr of the a and fl chains of C3 Exposure of normal EC3bBb to C3 resulted in no further deposition of C3b, suggesting that the activity of the C3 convertase was inhibited by membrane regulators of the APC (Fig 3) . C3 convertase activity was observed on the AET cells; however, convertase activity on AET cells was only 53% as great as that on anti-DAF-treated normal erythrocytes (Fig 3) . Thus, in contrast to MIRL and CRI, the structural (Table 1 ) and functional (Fig 3) integrity of DAF is only partially disrupted by AET.
As discussed above, CR1 also has decay-accelerating activity. To delineate more precisely the membrane constituents that regulate C3 convertase activity on human erythrocytes, normal and AET cells were incubated with anti-DAF, anti-MIRL, and anti-CR1 either alone or in combination, and the effects of those treatments on C3 convertase activity were analyzed by using the procedure described above. When AET cells were incubated with anti-DAF, C3 convertase activity was much greater than that on either AET cells or on normal cells treated with anti-DAF (Fig 4) . Those results confirmed that AET cells have residual DAF activity. The fact that the anti-DAFtreated AET cells had greater convertase activity than anti-DAF-treated normal cells, however, is consistent with the hypothesis that a membrane constituent other than DAF also regulates C3 convertase activity and that the functional activity of that constituent is destroyed by AET.
Inhibition of MIRL function had no effect on C3 convertase activity (Fig 4) . Further, when both DAF and MIRL were blocked simultaneously, convertase activity was equivalent to that observed with DAF alone was blocked (Fig 4) . Those results are consistent with the concept that MIRL has no direct effect on components of the C3 amplification convertase of the APC.
Inhibition of CR1 function had no effect on convertase activity (Fig 4) . However, when both DAF and CRl were blocked simultaneously, C3 convertase activity was equivalent to that observed when DAF function on AET cells was completely inhibited (Fig 4) . Those results show that DAF can control convertase activity in the absence of CR1. However, by blocking DAF function the regulatory effect of CR1 becomes apparent. The observation that convertase activity on anti-DAF-treated AET cells is equivalent to that on normal cells treated with a combination of anti-DAF and anti-CR1 is consistent with the hypothesis that AET destroys the decay-accelerating activity of CRl as well as the cofactor activity. Susceptibility of AET erythrocytes to acidijied serum lysis. In the experiments described above, isolated components were used to assess C3 convertase activity. To test the effects of AET treatment on APC activity in a whole serum system, erythrocytes were incubated in acidified serum. The acidified serum used in these experiments contained Mgl EGTA so that classical pathway of complement but not APC activity was inhibited. The mechanism whereby acidification of serum favors activation of the APC appears to involve the binding of factor B to C3b. At acid pH, the binding affinity of factor B for C3b is enhanced, and as a consequence, formation of the amplification C3 convertase of the APC (C3bBb) is fa~ored!~,~' Like PNH erythrocytes, AET cells are hemolyzed in acidified serum, but normal erythrocytes are resistant to this process (Fig 5A) . By blocking residual DAF activity, the susceptibility of AET cells is markedly enhanced (Fig  5A) . Those results confirm that DAF activity is present on AET cells, and that DAF participates in regulation of susceptibility to acidified serum. In contrast to the situation with AET cells, inhibition of DAF activity has only a modest effect on susceptibility of normal erythrocytes to acidified serum lysis (Fig 5A) . Those results show that other membrane constituents, in addition to DAF, influence susceptibility to acidified serum and that those constituents are inactivated by AET.
Following incubation in acidified serum, normal erythrocytes have bound relatively small amounts of activated C3. Those results indicate that membrane constituents working in concert with serum factors inhibit C3 convertase activity ( Fig 5B) . As anticipated, anti-DAF-treated normal erythrocytes have bound greater amounts of activated C3 than untreated normal cells following incubation in acidified serum (Fig 5B) . Those results were anticipated because by blocking DAF function on normal erythrocytes, membrane control of C3 convertase activity is at least partially inhibited.
AET cells bound approximately the same amount of activated C3 as anti-DAF-treated normal erythrocytes. MIRL, and CRl either alone or in combination was inhibited on normal and AET erythrocytes. ECBb, (0) and ECBb, (0) were generated as described in the legend t o Fig 3, and cell-bound C3b was quantified. The bars depict the mean 2 SEM (n = 3). When isolated components are used, DAF and CR1 control C3 convertase activity. However, the effects of CR1 are manifested only if the function of DAF is blocked.
Inasmuch as AET cells have approximately 50% of the normal amount of DAF activity, those results suggested
that membrane constituents, in addition to DAF, control C3 convertase activity and that those constituents are inactivated by AET. Evidence supporting this interpretation was provided by experiments in which residual DAF activity on AET cells was blocked with antibody. Following incubation in acidified serum, anti-DAF-treated AET cells had bound much greater amounts of activated C3 than normal cells treated with anti-DAF (Fig 5B) .
Erythrocyte regulation of APC C3 convertase activity using a whole serum system. To determine if C3 convertase activity using a whole serum system is controlled by the same membrane constituents that regulate convertase activity when isolated components of the convertase are used, normal and AET erythrocytes were incubated with anti-DAF, anti-CR1, and anti-MIRL either alone or in combination. After washing, the cells were incubated in acidified serum, and C3 deposition was subsequently quantified (Figs 6 and 7).
Consistent with the results shown in Fig 5B, the amount of activated C3 bound to AET cells was less than that bound to anti-DAF-treated erythrocytes (Fig 6) . Further, anti-DAF-treated AET cells bound greater amounts of activated C3 than anti-DAF-treated normal cells (Fig 6) .
As was the case using isolated components (Fig 4) , inhibition of CR1 had no effect on convertase activity in the whole serum system. However, in contrast to the experiments using isolated components, simultaneous inhibition of DAF and CRl did not cause increased deposition of C3 above that seen when the function of DAF alone was blocked (Fig 6) . Those results indicate that, in a whole The amount of C3 bound was subsequently quantitated by using a radiolabeled MoAb. The bars depict the mean r SEM (n = 6). Blocking DAF function on AET cells increased C3 convertase activity.
For serum system, CR1 is not an important regulator of C3 convertase activity. When normal erythrocytes were incubated with a combination of anti-DAF, anti-CR1, and anti-MIRL, C3 deposition was equivalent to that observed with anti-DAF-treated AET cells (Fig 6) suggested the possibility that, in a whole serum system, MIRL influenced the functional activity of the AFT C3 convertase. To test that hypothesis, the functional activity of MIRL was inhibited on normal cells (Fig 7) . Following incubation in acidified serum, normal erythrocytes that had been treated with anti-MIRL had bound more activated C3 than anti-DAF-treated normal cells (Fig 7) . Thus, in a whole serum system MIRL is an important regulator of C3 convertase activity. Normal cells treated with both anti-DAF and anti-MIRL had bound as much activated C3 as anti-DAF-treated AET cells (Fig 7) . Those results indicate that DAF and MIRL act in concert to control C3 convertase on erythrocytes when the AFT is activated in a whole serum system.
Regulation of susceptibility of erythrocytes to acidijied serum lysis. Normal human erythrocytes are resistant to acidified serum lysis, and inhibition of CR1 function has no effect on susceptibility (Fig 8) . Following inhibition of DAF function, approximately 20% of the cells were hemolyzed by acidified serum (Fig 8) . Simultaneous inhibition of both DAF and CR1 caused a modest increase in susceptibility above that seen when DAF alone was blocked (Fig 8) . In contrast, inhibition of MIRL function caused 100% susceptibility to acidified serum (Fig 8) . Those results show that susceptibility to acidified serum is controlled primarily by MIRL. In this system, MIRL appears to regulate the activity of both the APC C3 convertase and the MAC. For personal use only. on October 30, 2017. by guest www.bloodjournal.org From 50% of erythrocyte DAF is inactivated by AET while essentially all of the activity of CR1 and MIRL is destroyed. These observations establish the basis for the similarities and differences between AET and PNH erythrocytes in their interactions with complement.
AET erythrocytes resemble PNH I11 cells in that, following incubation with activated CoF complexes and human serum (the complement source), the cells are hemolyzed because they fail to regulate formation of the As a consequence, both AET and PNH I11 erythrocytes have bound relatively large amounts of C5b-9."," This process is controlled by MIRL, but DAF does not Both PNH and AET cells lack MIRL activity. In the case of PNH 111 cells, the protein is ab~ent,~.'' while for AET cells, MIRL is chemically inactivated.
Both AET and PNH 111 erythrocytes are abnormally susceptible to hemolysis initiated by the classical p a t h~a y .~' However, during this process PNH erythrocytes bind greater amounts of activated C3 than AET cells (although AET cells bind more activated C3 than normal erythrocyte^).^^ PNH 111 cells are profoundly deficient in both DAF and MIRL," while AET cells have no functional MIRL but have approximately 50% of normal DAF function. Thus, the difference in C3 binding appears to be due to the fact that the residual DAF activity on AET cells partially controls the classical pathway C3 convertase. The effects of MIRL on the classical pathway C3 convertase have not been determined.
Following incubation in acidified serum (a process that induces activation of the APC), both PNH 111 and AET cells are and both have bound relatively large amounts of activated C3.38346 The studies reported here have shown that, in acidified serum, the activity of the APC C3 convertase is controlled by MIRL as well as by DAF. Thus, the binding of activated C3 to AET cells is due to absence of MIRL function as well as to the partial inactivation of DAF. In experiments that compared binding following incubation in acidified serum, AET and PNH 111 cells were observed to bind equivalent amounts C3b (not shown). Those results suggest that, in acidified serum in the absence of normal MIRL function, the residual DAF activity on AET cells is functionally insignificant.
Another difference between AET and PNH cells is that AET cells have no CR1 activity while PNH I11 cells have a partial defi~iency.~~"~ Our studies have shown that CR1 has regulatory activity for the APC C3 convertase (Fig 4) . While CRl was originally isolated based on its capacity to decay accelerate the APC C3 convertase on sheep cells,' we are unaware of previous studies that have shown that CR1 functions in situ to regulate the convertase on human erythrocytes. However, for the inhibitory activity of CR1 to be observed, DAF function must be blocked (Fig 4) . The inhibitory activity of CR1 was observed using isolated components of the APC. In the acidified serum lysis assay, however, CR1 had no obvious effect on APC activity even if DAF function were blocked (Fig 6) . Thus, in a whole serum system, the inhibitory activity of CR1 may be obscured by the presence of factor H.
Even though the average amount of CR1 on PNH erythrocytes is less than normal, because the normal range for CR1 expression is extremely wide, the absolute number of CR1 molecules on PNH erythrocytes usually falls within the normal range.33"5 Further, rigorous studies have shown that CR1 function on PNH cells is Together, those observations suggest that the partial deficiency of CR1 does not make an important contribution to the aberrant interaction of PNH erythrocytes with complement, especially in a whole serum system.
The observation that anti-MIRL-treated normal erythrocytes bound large amounts of activated C3 following incubation in acidified serum was unexpected because previous studies had shown that MIRL inhibits complementmediated lysis by blocking formation of the MAC.9 Unlike DAF and CR1, the effects of blocking MIRL function on C3 convertase activity were not observed when purified components were used (Fig 4) . The simplest interpretation of those results is that MIRL requires a serum cofactor to regulate APC C3 convertase activity. Studies aimed at investigating this hypothesis are being undertaken.
A number of different reagents have been used to induce the PNH phenotype in normal e r y t h r o~y t e s .~~~~~ Our studies suggest that the sulfhydryl compounds used for this purpose (eg, AET, glutathione, cysteine, and dithiothreitol) work by disrupting intrachain disulphide bonds that are critical for the structural and functional integrity of membrane constituents that regulate complement. AET was used in these studies because of the consistency and reproducibility of its effects, and the fact that in previous investigations complement interactions with AET and PNH cells have been
The conditions for AET treatment were selected based on the results of studies by Sirchia and Dacie3' that showed treatment with an 8% solution for 9 minutes at 37°C produced a cell that resembled PNH 111 cells in complement lysis sensitivity assay. Incubation for shorter periods of time produced cells that were less sensitive to complement, suggesting that the functional activity of the membrane regulatory proteins had been less completely disrupted.
DAF and CR1 share a considerable amount of structural homology.53 Both proteins are comprised largely of a series of contiguous short consensus repeats of approximately 60 amino acids with each repeat containing four cysteines. The fact that AET completely inactivates CR1 but not DAF suggests that in situ, tertiary structural characteristics of DAF protect some disulfides from reduction by AET.
Although not structurally related to DAF and CR1, the derived amino acid sequence shows that MIRL has 10 cysteine r e~i d u e s . '~~~~~~' Clearly, other membrane constituents that depend on intrachain disulfides for their structural and functional integrity will also be affected by AET. For example, erythrocyte acetylcholinesterase (a GPI-linked protein that is deficient in PNH) is partially inactivated by sulfhydryl reagent^.^^'^^ PNH I11 erythrocytes are also deficient in HRF/C8bp, but the relationship of this deficiency to the enhanced susceptibility to complement-mediated hemolysis is not entirely clear. Recently, Young et a154 reported that HRF/ C8bp is immunochemically related to C8 and C9 through The studies reported here have demonstrated that, while there are similarities between PNH and AET cells, important differences also exist. Accordingly, it would be inappropriate to imply that normal erythrocytes are transformed into PNH cells by treatment with AET. Nonetheless, AET cells have provided interesting insights into the mechanisms by which membrane constituents regulate the activity of complement.
